Skip to Content

Long-term remission found with combination therapy for young patients with CLL

A 2.5-year time-limited regimen with combination treatment of ibrutinib and FCR shows potential to generate long-term remission for a group of young patients with chronic lymphocytic leukemia.

ASH21 poster hall

Få tilgang til artikkelen

Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.

Back to top